PEGylated cationic liposomal-oxaliplatin display impressive anticancer efficacy by dual-targeting of immunosuppressive populations and cancer-cells

Published in 2019 by Lars Petersen, Lars Ringgaard, Fredrik Melander

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload